NCT02631096View on ClinicalTrials.gov

Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 18, 2018

Study Completion Date

May 18, 2018

Conditions
Hepatitis B, Chronic
Interventions
DRUG

ARB-001467

An IV infusion of ARB-001467

OTHER

Placebo

An IV infusion of placebo

Trial Locations (4)

1010

Auckland Clinical Studies Ltd, Auckland

3004

The Alfred, Gastroenterology and Hepatology, Melbourne

3168

Monash Health, Gastroenterology and Hepatology, Clayton

6009

Linear Clinical Research Ltd, Nedlands

Sponsors
All Listed Sponsors
lead

Arbutus Biopharma Corporation

INDUSTRY